Drugs for Gastrointestinal Diseases Practice Questions

Q: Which of the following statements about Octreotide is incorrect?

It acts as an absorbent.. ### Explanation **Correct Answer: D. It acts as an absorbent.** **1. Why Option D is the correct (incorrect statement):** Octreotide is a **pharmacological agent**, specifically a synthetic octapeptide analogue of the hormone somatostatin. It does not act physically as an absorbent (like Kaolin or Pectin, which bind toxins and water in the gut lumen). Instead, it works by binding to specific somatostatin receptors (SSTR-2, 3, and 5) to inhibit the secretion of various hormones and intestinal fluids. **2. Analysis of Incorrect Options (Correct Statements):** * **Option A:** Octreotide is indeed a **somatostatin analogue**. It is preferred over natural somatostatin because it has a much longer half-life (approx. 1.5 hours vs. 2 minutes) and can be administered subcutaneously or intravenously. * **Option B:** It is a standard treatment for **refractory secretory diarrhea** associated with AIDS and chemotherapy. It works by inhibiting intestinal secretion and enhancing water/electrolyte absorption. * **Option C:** It is the drug of choice for symptomatic relief in **Carcinoid Syndrome** and VIPomas. It suppresses the release of serotonin and other vasoactive peptides that cause flushing and diarrhea. **3. Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits the release of Growth Hormone (GH), Glucagon, Insulin, Gastrin, and VIP. * **Other Uses:** * **Acromegaly:** To reduce GH levels. * **Esophageal Varices:** It causes splanchnic vasoconstriction, reducing portal pressure (though Terlipressin is often preferred). * **Dumping Syndrome:** Post-gastrectomy. * **Key Side Effect:** **Gallstones (Cholelithiasis)** due to inhibition of cholecystokinin (CCK) release and reduced gallbladder contractility. * **Steatorrhea:** May occur due to inhibition of pancreatic enzyme secretion.

Q: All of the following are true for metoclopramide except?

Stimulates the chemoreceptor trigger zone. **Explanation:**Metoclopramide is a substituted benzamide, a prokinetic agent, and a potent antiemetic [1]. The correct answer is **Option C** because metoclopramide **blocks** (antagonizes) the Chemoreceptor Trigger Zone (CTZ), rather than stimulating it. **Why Option C is the correct answer (The Exception):**Metoclopramide acts as an antiemetic primarily by blocking **D2 receptors** in the CTZ of the medulla. By inhibiting these receptors, it raises the threshold for vomiting. Stimulating the CTZ would induce nausea and vomiting, which is the opposite of metoclopramide’s clinical use. **Analysis of Incorrect Options:** * **Option A (Chemically related to procainamide):** This is true. Metoclopramide is a derivative of para-aminobenzoic acid (PABA), making it chemically related to the antiarrhythmic drug procainamide, though it lacks significant antiarrhythmic activity. * **Option B (Speeds gastric emptying):** This is true. As a **prokinetic**, it increases lower esophageal sphincter tone and enhances gastric motility/emptying by blocking inhibitory D2 receptors and enhancing Acetylcholine release (5-HT4 agonism) in the enteric nervous system [2]. * **Option D (Blocks D2 receptors):** This is true. Its primary mechanism of action both centrally (antiemetic) and peripherally (prokinetic) involves D2 receptor antagonism. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Due to central D2 blockade, it can cause **Extrapyramidal Symptoms (EPS)** like acute dystonia and Parkinsonism. It also increases prolactin levels, leading to galactorrhea or gynecomastia. * **Drug of Choice:** It is frequently used for Diabetic Gastroparesis and as an antiemetic in post-operative states or chemotherapy [1]. * **Contraindication:** It must be avoided in patients with **Pheochromocytoma** (can cause hypertensive crisis) and mechanical GI obstruction.

Q: Which of the following drugs is NOT used in the management of IBS-Constipation?

Alosetron. **Explanation:** The correct answer is **Alosetron** because it is used in the management of **IBS-Diarrhea (IBS-D)**, not IBS-Constipation (IBS-C). **Mechanism and Rationale:** * **Alosetron** is a potent **5-HT₃ receptor antagonist**. By blocking these receptors in the enteric nervous system, it reduces intestinal motility, decreases secretions, and increases visceral pain thresholds. Because it slows colonic transit, it is indicated specifically for severe, diarrhea-predominant IBS in women who have not responded to conventional therapy. **Analysis of Incorrect Options (Drugs used for IBS-C):** * **Lubiprostone (Option A):** A **Chloride Channel Activator (Type-2)**. It increases fluid secretion into the intestinal lumen, which softens stool and accelerates transit time. * **Tegaserod (Option B):** A **5-HT₄ receptor partial agonist**. Stimulation of 5-HT₄ receptors triggers the peristaltic reflex and promotes gastric emptying and intestinal transit. (Note: Its use is restricted due to cardiovascular risks). * **Linaclotide (Option D):** A **Guanylate Cyclase-C (GC-C) agonist**. It increases intracellular cGMP, which activates the CFTR channel to secrete chloride and bicarbonate into the lumen, facilitating bowel movements and reducing visceral pain. **High-Yield NEET-PG Pearls:** 1. **Alosetron Warning:** It is associated with a rare but serious risk of **Ischemic Colitis**, requiring a strict prescribing program. 2. **Prucalopride:** Another 5-HT₄ agonist (highly selective) used for chronic constipation. 3. **Eluxadoline:** A mu-opioid receptor agonist used for IBS-D. 4. **Rifaximin:** A non-absorbable antibiotic often used for IBS-D to modulate gut flora.

Q: Which drugs are used in the treatment of pruritus in Primary Biliary Cholangitis (PBC)?

All of the above. **Explanation:** Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease where the accumulation of bile acids and other pruritogens (like endogenous opioids and lysophosphatidic acid) leads to severe, debilitating pruritus. The management follows a stepwise pharmacological approach: 1. **Cholestyramine (Option C):** This is the **first-line treatment**. It is a bile acid sequestrant (resin) that binds bile salts in the intestinal lumen, preventing their enterohepatic circulation and promoting fecal excretion. * *Clinical Pearl:* It must be taken 1 hour after or 4 hours before other drugs to avoid interference with absorption. 2. **Rifampicin (Option A):** This is the **second-line treatment**. It acts as a potent inducer of the Pregnane X Receptor (PXR). This increases the metabolism of bile acids and pruritogens (via CYP3A4) and enhances their excretion. 3. **Naltrexone (Option B):** This is an **opioid antagonist**. Cholestasis leads to an increased "opioidergic tone," which contributes to the sensation of itching. Naltrexone blocks these opioid receptors to provide relief. **Why "All of the Above" is correct:** All three drugs target different pathways of the cholestatic itch—sequestration (Cholestyramine), enzymatic metabolism (Rifampicin), and receptor antagonism (Naltrexone). Therefore, all are established therapeutic options for PBC-associated pruritus. **High-Yield Facts for NEET-PG:** * **Sertraline** (an SSRI) is often used as a fourth-line agent. * **Ursodeoxycholic acid (UDCA)** is the first-line drug for the *progression* of PBC but is generally ineffective for treating the *symptom* of pruritus. * **Plasmapheresis** or **Liver Transplant** are considered for refractory cases.

Q: Proton pump inhibitors (PPIs) are used in which of the following conditions?

All of the above. **Explanation:** Proton Pump Inhibitors (PPIs) like Omeprazole and Pantoprazole are the most potent inhibitors of gastric acid secretion [1], [2]. They work by irreversibly inhibiting the **H+/K+ ATPase pump** (the final common pathway for acid secretion) in the gastric parietal cells [1], [2]. **Why "All of the above" is correct:** * **Zollinger-Ellison Syndrome (ZES):** This is a gastrin-secreting tumor (gastrinoma) leading to extreme gastric acid hypersecretion. PPIs are the **drugs of choice** here [1], often requiring higher doses than standard peptic ulcer disease to control the massive acid output. * **NSAID-induced Peptic Ulcer:** NSAIDs inhibit prostaglandin synthesis, weakening the mucosal barrier. PPIs are highly effective in both the **healing and prevention** of NSAID-induced gastric and duodenal ulcers [1]. * **Gastroesophageal Reflux Disease (GERD):** PPIs are the mainstay of treatment for symptomatic relief and healing of erosive esophagitis [1], [2]. They are superior to H2 blockers in maintaining a gastric pH >4, which is essential for esophageal healing [1]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** PPIs are **prodrugs** that require an acidic environment for activation (converted to sulfenamide) [1]. 2. **Administration:** They should be taken **30–60 minutes before meals** (usually breakfast) because the number of H+/K+ ATPase pumps is highest after a period of fasting. 3. **Drug Interactions:** Omeprazole can inhibit CYP2C19, potentially reducing the activation of **Clopidogrel**. 4. **Long-term Side Effects:** Chronic use is associated with Vitamin B12 deficiency, hypomagnesemia, and an increased risk of *C. difficile* infections and osteoporotic fractures (due to decreased calcium absorption).

Q: Which of the following is NOT an osmotic laxative?

Bisacodyl. ### Explanation The correct answer is **D. Bisacodyl**. **1. Why Bisacodyl is the correct answer:** Bisacodyl is classified as a **stimulant (irritant) laxative**, not an osmotic one. It works by directly irritating the sensory nerve endings in the colonic mucosa and stimulating the myenteric plexus. This increases propulsive peristaltic activity and alters electrolyte transport, leading to fluid accumulation in the gut lumen. It is commonly used for acute constipation or bowel preparation before procedures. **2. Why the other options are incorrect:** Osmotic laxatives are non-absorbable substances that retain water in the intestinal lumen through osmotic pressure, softening the stool and increasing bolus volume. * **Sorbitol:** A non-absorbable sugar alcohol that acts as an osmotic agent. * **Magnesium Hydroxide (Milk of Magnesia):** A saline osmotic laxative. Magnesium ions are poorly absorbed and draw water into the intestines. * **Polyethylene glycol (PEG):** A high-molecular-weight polymer that is metabolically inert and non-absorbable. It is considered the gold standard for chronic constipation and whole-gut irrigation. **3. NEET-PG High-Yield Clinical Pearls:** * **Mechanism of Stimulant Laxatives:** They can cause "cathartic colon" (loss of normal colonic motility) with chronic overuse. * **Lactulose:** Another high-yield osmotic laxative; it is also used in **Hepatic Encephalopathy** to trap ammonia ($NH_3$) as ammonium ions ($NH_4^+$) in the gut. * **Bulk-forming agents:** Psyllium (Ispaghula) and Methylcellulose are the first-line treatments for most chronic constipation cases. * **Docusate:** Acts as a stool softener (surfactant/emulsifier) rather than a stimulant or osmotic agent.

Q: Which of the following is beneficial in NSAID-induced gastric ulcer?

PGE1 agonist. The correct answer is **A. PGE1 agonist**. **Mechanism of Action:** NSAIDs induce gastric ulcers primarily by inhibiting the enzyme **Cyclooxygenase-1 (COX-1)**, which leads to a deficiency in endogenous prostaglandins (PGE2 and PGI2) in the gastric mucosa [2], [3]. These prostaglandins are essential for "cytoprotection" as they decrease gastric acid secretion, increase bicarbonate production, and enhance mucosal blood flow [4]. **Misoprostol**, a synthetic **PGE1 analog (agonist)**, acts as a replacement for these lost prostaglandins [1]. It binds to EP3 receptors on parietal cells to inhibit cAMP-mediated acid secretion, making it the drug of choice for the prevention of NSAID-induced ulcers [1]. **Analysis of Incorrect Options:** * **B. PGE2 agonist:** While endogenous PGE2 is naturally cytoprotective [2], the specific pharmacological agent used in clinical practice for NSAID-induced ulcer prophylaxis is a PGE1 derivative (Misoprostol) [1]. PGE2 analogs (like Dinoprostone) are primarily used in obstetrics for cervical ripening. * **C & D. PGD and PGF2 agonists:** These prostaglandins do not play a significant role in gastric mucosal protection. PGF2α (e.g., Carboprost, Latanoprost) is involved in uterine contraction and intraocular pressure regulation, while PGD2 is primarily involved in allergic responses and sleep regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** While Misoprostol is the specific physiological antagonist for NSAID-induced ulcers, **Proton Pump Inhibitors (PPIs)** are more commonly used in clinical practice due to better tolerability [2]. * **Contraindication:** Misoprostol is strictly **contraindicated in pregnancy** (Category X) because it causes uterine contractions and can lead to abortion. * **Side Effects:** The most common side effect of Misoprostol is **diarrhea** and abdominal cramps.

Q: Which one of the following drugs exacerbates reflux esophagitis?

Theophylline. **Explanation:** The primary pathophysiological mechanism behind Gastroesophageal Reflux Disease (GERD) or reflux esophagitis is the relaxation of the **Lower Esophageal Sphincter (LES)** [1][3]. Any drug that decreases LES tone will exacerbate the condition. **Why Theophylline is correct:** Theophylline is a methylxanthine used in asthma and COPD [5]. It acts by inhibiting the enzyme **phosphodiesterase (PDE)**, leading to increased levels of intracellular **cAMP** [4]. In smooth muscles, elevated cAMP causes relaxation. When this occurs at the LES, it reduces the pressure barrier between the stomach and esophagus, allowing acidic gastric contents to reflux upwards, thereby exacerbating esophagitis [1]. **Why the other options are incorrect:** * **Cisapride:** This is a prokinetic agent that acts as a 5-HT4 receptor agonist [2]. It **increases** LES tone and enhances gastric emptying, making it a drug used to *treat* GERD, not exacerbate it. However, it is largely restricted due to the risk of **QT interval prolongation** [2]. * **Metoclopramide:** A D2 receptor antagonist with prokinetic properties. Like cisapride, it **increases** LES pressure and promotes upper GI motility, thus helping to *prevent* reflux. * **Chlorpropamide:** This is a first-generation sulfonylurea used in Diabetes Mellitus. It has no significant pharmacological effect on LES tone or esophageal motility. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs that exacerbate GERD:** Anticholinergics, Nitrates, Calcium Channel Blockers (CCBs), Progesterone, and Beta-agonists (all relax smooth muscle). * **Prokinetic of choice:** While Cisapride is effective, it is largely restricted due to the risk of **QT interval prolongation** (Torsades de pointes) [2]. * **Theophylline Toxicity:** Remember that Theophylline has a narrow therapeutic index; its metabolism is inhibited by Cimetidine and Erythromycin, increasing the risk of toxicity.

Q: Which of the following drugs does NOT cause peptic ulcer?

Propylthiouracil. **Explanation:** The correct answer is **Propylthiouracil (PTU)**. PTU is an antithyroid drug used in the management of hyperthyroidism and Graves' disease. Its primary mechanism involves inhibiting the enzyme thyroid peroxidase and blocking the peripheral conversion of T4 to T3 [1]. It is **not** associated with gastric mucosal injury or peptic ulcer disease (PUD). Its major side effects include agranulocytosis, hepatotoxicity, and ANCA-associated vasculitis [3]. **Analysis of Incorrect Options:** * **NSAIDs (e.g., Aspirin, Ibuprofen):** These are the most common pharmacological cause of PUD. They inhibit the COX-1 enzyme, leading to decreased synthesis of protective prostaglandins ($PGE_2$ and $PGI_2$), which are essential for maintaining the gastric mucosal barrier and bicarbonate secretion [2]. * **Clopidogrel:** While not directly ulcerogenic like NSAIDs, this antiplatelet agent impairs the healing of pre-existing gastric erosions by inhibiting platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF) required for mucosal repair. This significantly increases the risk of upper GI bleeding. * **Mycophenolate Mofetil (MMF):** This immunosuppressant is notorious for GI toxicity. It causes direct mucosal damage and inhibits the proliferation of rapidly dividing enterocytes, frequently leading to gastritis, erosions, and "MMF-induced colitis." **High-Yield Clinical Pearls for NEET-PG:** * **Steroids alone** have a low risk of causing ulcers, but when combined with **NSAIDs**, the risk of PUD increases exponentially (synergistic effect). * **Bisphosphonates** (e.g., Alendronate) and **Potassium chloride tablets** are other common causes of drug-induced esophageal and gastric ulcers. * **Prophylaxis:** For patients on long-term NSAIDs with high ulcer risk, **Misoprostol** ($PGE_1$ analogue) or **PPIs** are the drugs of choice for prevention.

Question 1

Which of the following statements about Octreotide is incorrect?

Accepted Answer

It acts as an absorbent.

Answer

It is a somatostatin analogue.

Answer

It is used in secretory diarrhea in AIDS.

Answer

It is used in carcinoid syndrome.

Question 2

All of the following are true for metoclopramide except?

Accepted Answer

Stimulates the chemoreceptor trigger zone

Answer

Chemically related to procainamide

Answer

Speeds gastric emptying

Answer

Blocks D2 receptors

Question 3

Which of the following drugs is NOT used in the management of IBS-Constipation?

Accepted Answer

Alosetron

Answer

Lubiprostone

Answer

Tegaserod

Answer

Linaclotide

Question 4

Which drugs are used in the treatment of pruritus in Primary Biliary Cholangitis (PBC)?

Accepted Answer

All of the above

Answer

Rifampicin

Answer

Naltrexone

Answer

Cholestyramine

Question 5

Proton pump inhibitors (PPIs) are used in which of the following conditions?

Accepted Answer

All of the above

Answer

Zollinger-Ellison syndrome

Answer

NSAID-induced peptic ulcer

Answer

Gastroesophageal reflux disease

Question 6

Which of the following is NOT an osmotic laxative?

Accepted Answer

Bisacodyl

Answer

Sorbitol

Answer

Magnesium Hydroxide

Answer

Polyethylene glycol

Question 7

All of the following are true regarding a patient with acid peptic disease except?

Accepted Answer

Omeprazole may help ulcers refractory to H2 blockers.

Answer

Misoprostol is the drug of choice in patients on NSAIDs.

Answer

Duodenal ulcer is preventable by the use of single nighttime H2 blockers.

Answer

Misoprostol is the drug of choice in pregnant patients.

Question 8

Which of the following is beneficial in NSAID-induced gastric ulcer?

Accepted Answer

PGE1 agonist

Answer

PGE2 agonist

Answer

PGD agonist

Answer

PGF2 agonist

Question 9

Which one of the following drugs exacerbates reflux esophagitis?

Accepted Answer

Theophylline

Answer

Cisapride

Answer

Chlorpropamide

Answer

Metoclopramide

Question 10

Which of the following drugs does NOT cause peptic ulcer?

Accepted Answer

Propylthiouracil

Answer

Clopidogrel

Answer

NSAID

Answer

Mycophenolate mofetil

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?